184 related articles for article (PubMed ID: 19811899)
1. Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parameters.
Sakamoto K; Taniguchi H; Kondoh Y; Johkoh T; Sumikawa H; Kimura T; Nishiyama O; Kato K; Kataoka K; Ono K; Kitaichi M; Hasegawa Y
Respir Med; 2010 Jan; 104(1):127-33. PubMed ID: 19811899
[TBL] [Abstract][Full Text] [Related]
2. Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia.
Ichiyasu H; Ichikado K; Yamashita A; Iyonaga K; Sakamoto O; Suga M; Kohrogi H
Respiration; 2012; 83(3):190-7. PubMed ID: 21555868
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis.
Kumánovics G; Görbe E; Minier T; Simon D; Berki T; Czirják L
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-138-44. PubMed ID: 24773853
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
Hesselstrand R; Wildt M; Bozovic G; Andersson-Sjöland A; Andréasson K; Scheja A; Westergren-Thorsson G; Bjermer L; Wuttge DM
Respir Med; 2013 Jul; 107(7):1079-86. PubMed ID: 23660398
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias.
Ryu YJ; Chung MP; Han J; Kim TS; Lee KS; Chun EM; Kyung SY; Jeong SH; Colby TV; Kim H; Kwon OJ
Respir Med; 2007 Mar; 101(3):655-60. PubMed ID: 16919929
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants.
Walsh SL; Sverzellati N; Devaraj A; Keir GJ; Wells AU; Hansell DM
Thorax; 2014 Mar; 69(3):216-22. PubMed ID: 24127020
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and disease behaviour of pathologically proven fibrotic non-specific interstitial pneumonia.
Yamakawa H; Kitamura H; Takemura T; Ikeda S; Sekine A; Baba T; Iwasawa T; Hagiwara E; Sato S; Ogura T
Respirology; 2018 Nov; 23(11):1032-1040. PubMed ID: 29693298
[TBL] [Abstract][Full Text] [Related]
12. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients.
Sumikawa H; Johkoh T; Ichikado K; Taniguchi H; Kondoh Y; Fujimoto K; Tateishi U; Hiramatsu T; Inoue A; Natsag J; Ikemoto M; Mihara N; Honda O; Tomiyama N; Hamada S; Nakamura H; Müller NL
Radiology; 2006 Oct; 241(1):258-66. PubMed ID: 16908678
[TBL] [Abstract][Full Text] [Related]
13. Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases.
Cho EJ; Park KJ; Ko DH; Koo HJ; Lee SM; Song JW; Lee W; Lee HK; Do KH; Chun S; Min WK
Ann Lab Med; 2019 May; 39(3):245-251. PubMed ID: 30623616
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characterization of CA19-9 in patients with interstitial pneumonia showing pathological nonspecific interstitial pneumonia pattern].
Totani Y; Saito Y; Miyachi H; Yoneda Y; Shimizu H; Hoshino T; Hayashi M; Uchiyama Y; Isogai S; Matsui K; Hashimoto Y; Umemoto M; Sasaki F; Okazawa M; Sakakibara H
Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):77-83. PubMed ID: 15770937
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
[TBL] [Abstract][Full Text] [Related]
17. [A high-resolution CT and pathological study of nonspecific interstitial pneumonia].
Cai HR; Dai LJ; Cao M; Meng FQ; Wei JY
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):32-6. PubMed ID: 18366904
[TBL] [Abstract][Full Text] [Related]
18. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients.
Cottin V; Donsbeck AV; Revel D; Loire R; Cordier JF
Am J Respir Crit Care Med; 1998 Oct; 158(4):1286-93. PubMed ID: 9769293
[TBL] [Abstract][Full Text] [Related]
19. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time.
Silva CI; Müller NL; Hansell DM; Lee KS; Nicholson AG; Wells AU
Radiology; 2008 Apr; 247(1):251-9. PubMed ID: 18270375
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort.
Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D
Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
